$FHTX
Foghorn Therapeutics Inc.

2023 Q4 Form 10-Q Financial Statement

#000162828023036187 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $5.769M $17.48M $6.634M
YoY Change 37.88% 163.46% 16080.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.022M $8.310M $7.965M
YoY Change -10.68% 4.33% 37.14%
% of Gross Profit
Research & Development $24.21M $26.25M $26.93M
YoY Change -14.19% -2.51% 31.39%
% of Gross Profit
Depreciation & Amortization $852.0K $900.0K $900.0K
YoY Change 0.47% 0.0% 12.5%
% of Gross Profit
Operating Expenses $31.23M $34.56M $34.89M
YoY Change -13.43% -0.96% 32.66%
Operating Profit -$17.08M -$28.26M
YoY Change -39.56% 7.61%
Interest Expense $2.660M $2.750M $0.00
YoY Change -53.13% -100.0%
% of Operating Profit
Other Income/Expense, Net $678.0K $3.474M $2.490M
YoY Change -125.35% 39.52% 1275.69%
Pretax Income -$22.12M -$13.61M -$25.77M
YoY Change -23.42% -47.2% -1.19%
Income Tax $1.986M $700.0K $0.00
% Of Pretax Income
Net Earnings -$24.11M -$14.35M -$25.77M
YoY Change -16.55% -44.33% -1.19%
Net Earnings / Revenue -417.85% -82.07% -388.44%
Basic Earnings Per Share -$0.34 -$0.62
Diluted Earnings Per Share -$0.57 -$0.34 -$0.62
COMMON SHARES
Basic Shares Outstanding 42.22M shares 41.86M shares 41.67M shares
Diluted Shares Outstanding 42.03M shares 41.67M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $234.1M $259.9M $373.5M
YoY Change -32.31% -30.42% 209.08%
Cash & Equivalents $80.34M $70.31M $87.60M
Short-Term Investments $153.7M $189.6M $285.9M
Other Short-Term Assets $6.124M $5.600M $4.262M
YoY Change 9.34% 31.39% 37.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $240.2M $265.4M $377.8M
YoY Change -31.65% -29.73% 204.76%
LONG-TERM ASSETS
Property, Plant & Equipment $42.91M $45.10M $52.10M
YoY Change -13.13% -13.43% -10.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.823M $1.129M $2.368M
YoY Change 18.66% -52.32% -2.59%
Total Long-Term Assets $45.74M $47.98M $56.17M
YoY Change -14.49% -14.58% -9.57%
TOTAL ASSETS
Total Short-Term Assets $240.2M $265.4M $377.8M
Total Long-Term Assets $45.74M $47.98M $56.17M
Total Assets $285.9M $313.4M $433.9M
YoY Change -29.38% -27.77% 133.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.260M $6.496M $5.257M
YoY Change 15.63% 23.57% 37.58%
Accrued Expenses $16.92M $8.799M $10.12M
YoY Change 53.77% -13.07% -28.16%
Deferred Revenue $34.55M $28.35M $33.16M
YoY Change 5.27% -14.52% 2494.76%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.44M $52.01M $55.21M
YoY Change 5.85% -5.79% 186.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $304.7M $0.00 $58.00K
YoY Change 1050486.21% -100.0% -66.08%
Total Long-Term Liabilities $304.7M $0.00 $58.00K
YoY Change 1050486.21% -100.0% -99.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.44M $52.01M $55.21M
Total Long-Term Liabilities $304.7M $0.00 $58.00K
Total Liabilities $363.1M $370.8M $409.6M
YoY Change -10.29% -9.47% 289.78%
SHAREHOLDERS EQUITY
Retained Earnings -$471.6M -$447.5M -$344.3M
YoY Change 26.4% 29.97% 46.45%
Common Stock $4.000K $4.000K $4.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$77.19M -$57.39M $24.32M
YoY Change
Total Liabilities & Shareholders Equity $285.9M $313.4M $433.9M
YoY Change -29.38% -27.77% 133.21%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$24.11M -$14.35M -$25.77M
YoY Change -16.55% -44.33% -1.19%
Depreciation, Depletion And Amortization $852.0K $900.0K $900.0K
YoY Change 0.47% 0.0% 12.5%
Cash From Operating Activities -$27.54M -$27.20M -$19.99M
YoY Change -4.78% 36.1% -2.52%
INVESTING ACTIVITIES
Capital Expenditures $37.00K $100.0K -$330.0K
YoY Change -86.25% -130.3% 43.48%
Acquisitions
YoY Change
Other Investing Activities $37.42M $38.60M $46.38M
YoY Change -699.9% -16.78% -198.48%
Cash From Investing Activities $37.38M $38.50M $46.05M
YoY Change -674.54% -16.4% -197.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 186.0K 1.400M 333.0K
YoY Change 1062.5% 320.42% -34.06%
NET CHANGE
Cash From Operating Activities -27.54M -27.20M -19.99M
Cash From Investing Activities 37.38M 38.50M 46.05M
Cash From Financing Activities 186.0K 1.400M 333.0K
Net Change In Cash 10.03M 12.70M 26.40M
YoY Change -128.32% -51.89% -139.21%
FREE CASH FLOW
Cash From Operating Activities -$27.54M -$27.20M -$19.99M
Capital Expenditures $37.00K $100.0K -$330.0K
Free Cash Flow -$27.58M -$27.30M -$19.66M
YoY Change -5.53% 38.89% -3.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4572000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
370811000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
404771000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41803436 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
391959000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
377232000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26251000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26928000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8308000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7965000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
34559000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
34893000 usd
us-gaap Operating Expenses
OperatingExpenses
110834000 usd
us-gaap Operating Expenses
OperatingExpenses
100295000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17081000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-28259000 usd
us-gaap Interest Income Other
InterestIncomeOther
8215000 usd
CY2023Q3 fhtx Interest Income And Other Income Expense
InterestIncomeAndOtherIncomeExpense
721000 usd
CY2022Q3 fhtx Interest Income And Other Income Expense
InterestIncomeAndOtherIncomeExpense
651000 usd
fhtx Interest Income And Other Income Expense
InterestIncomeAndOtherIncomeExpense
2153000 usd
fhtx Interest Income And Other Income Expense
InterestIncomeAndOtherIncomeExpense
1956000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3474000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2490000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10368000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5255000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13607000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25769000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72080000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-79996000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
738000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2240000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-74320000 usd
us-gaap Net Income Loss
NetIncomeLoss
-79996000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42025938 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14345000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25769000 usd
us-gaap Net Income Loss
NetIncomeLoss
-79996000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
826000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1675000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2093000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4854000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
826000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1675000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2093000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4854000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13519000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27444000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72227000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84850000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
112000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4470000 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
151000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-29487000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-49350000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
96871000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
384000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3244000 usd
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1184000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
72401000 usd
CY2023Q3 fhtx Cash Payments Related Party
CashPaymentsRelatedParty
0 usd
CY2022Q3 fhtx Cash Payments Related Party
CashPaymentsRelatedParty
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42217126 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42217126 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41803436 shares
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1893000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3986000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447458000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-373138000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-57388000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
112000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
313423000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
404883000 usd
us-gaap Interest Income Other
InterestIncomeOther
3299000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.77
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42025938 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41672621 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41672621 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41888314 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41888314 shares
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102000 usd
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1116000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-30488000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24586000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1387000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4094000 usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
826000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-14345000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-57388000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1030000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3509000 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1995000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-27313000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
47632000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
334000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3801000 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1675000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25769000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
24323000 usd
us-gaap Net Income Loss
NetIncomeLoss
-79996000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13135000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10555000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2599000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2473000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
fhtx Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
3815000 usd
fhtx Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
2510000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
2156000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
721000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1297000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1068000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-300000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1082000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1457000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2129000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
547000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5505000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5313000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-28386000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10044000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90565000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
222536000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1187000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
941000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
67061000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
365006000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
175312000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
128132000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
107065000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-237815000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1592000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1747000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1592000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1747000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18092000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13532000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53922000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102869000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72014000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89337000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2686000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
58000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
204000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70306000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87604000 usd
CY2023Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1708000 usd
CY2022Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1733000 usd
us-gaap Net Income Loss
NetIncomeLoss
-74300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-80000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-447500000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
191475000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1894000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
189582000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
297570000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3992000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
293584000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
24957000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
23922000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
11164000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
8611000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
13793000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
15311000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2500000 usd
CY2023Q3 fhtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2967000 usd
CY2022Q4 fhtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
5262000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4692000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4743000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
839000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
678000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
318000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8799000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11001000 usd
CY2023Q3 fhtx Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9551175 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7878693 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1184497 shares
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4094000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3802000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13135000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10555000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
32800000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.031
fhtx Cash Payments Related Party
CashPaymentsRelatedParty
100000 usd
fhtx Cash Payments Related Party
CashPaymentsRelatedParty
100000 usd

Files In Submission

Name View Source Status
0001628280-23-036187-index-headers.html Edgar Link pending
0001628280-23-036187-index.html Edgar Link pending
0001628280-23-036187.txt Edgar Link pending
0001628280-23-036187-xbrl.zip Edgar Link pending
ex101-employmentagreementx.htm Edgar Link pending
fhtx-20230930.htm Edgar Link pending
fhtx-20230930.xsd Edgar Link pending
fhtx-20230930xex311.htm Edgar Link pending
fhtx-20230930xex312.htm Edgar Link pending
fhtx-20230930xex321.htm Edgar Link pending
fhtx-20230930xex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fhtx-20230930_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
fhtx-20230930_def.xml Edgar Link unprocessable
fhtx-20230930_cal.xml Edgar Link unprocessable
fhtx-20230930_lab.xml Edgar Link unprocessable
fhtx-20230930_pre.xml Edgar Link unprocessable